Literature DB >> 16323113

Carbapenem susceptibility discords among Acinetobacter isolates.

Ronald N Jones, Helio S Sader, Thomas R Fritsche, Paul R Rhomberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16323113     DOI： 10.1086/498754

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification.

Authors:  John S Esterly; Jamie Wagner; Milena M McLaughlin; Michael J Postelnick; Chao Qi; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2012-07-09       Impact factor: 5.191

2.  Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.

Authors:  C Routsi; M Pratikaki; E Platsouka; C Sotiropoulou; S Nanas; V Markaki; C Vrettou; O Paniara; H Giamarellou; C Roussos
Journal:  Infection       Date:  2010-03-12       Impact factor: 3.553

3.  Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit.

Authors:  Song Yee Kim; Ji Ye Jung; Young Ae Kang; Joo Eun Lim; Eun Young Kim; Sang Kook Lee; Seon Cheol Park; Kyung Soo Chung; Byung Hoon Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Moo Suk Park
Journal:  J Korean Med Sci       Date:  2012-07-25       Impact factor: 2.153

4.  The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates.

Authors:  Bojana Lukovic; Ina Gajic; Ivica Dimkic; Dusan Kekic; Sanja Zornic; Tatjana Pozder; Svetlana Radisavljevic; Nataša Opavski; Milan Kojic; Lazar Ranin
Journal:  Antimicrob Resist Infect Control       Date:  2020-07-06       Impact factor: 4.887
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.